We are live on ! Find out more
SFU

Stonehage Fleming (UK) Portfolio holdings

AUM $220M
1-Year Est. Return 0.72%
This Fund
S&P 500
This Quarter Est. Return
+5.67%
1 Year Est. Return
+0.72%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$248M
AUM Growth
+$11.4M
Cap. Flow
-$9.42M
Cap. Flow %
-3.8%
Top 10 Hldgs %
28.73%
Holding
357
New
54
Increased
32
Reduced
132
Closed
96

Top Buys

Rank Stock Value
1
CX icon
Cemex
CX
+$11.5M
2
DOG
ProShares Short Dow30
DOG
+$6.11M
3
BA icon
Boeing
BA
+$5.44M
4
EBAY icon
eBay
EBAY
+$3.1M
5
EDU icon
New Oriental
EDU
+$2.94M

Top Sells

Rank Stock Value
1
SH icon
ProShares Short S&P500
SH
+$6.22M
2
GPC icon
Genuine Parts
GPC
+$3.39M
3
OUTR
OUTERWALL INC
OUTR
+$3.38M
4
FLIR
FLIR Systems, Inc. (DE) Common Stock
FLIR
+$3.27M
5
HSIC icon
Henry Schein
HSIC
+$3.26M

Sector Composition

Rank Sector Weight
1 Technology 19.43%
2 Industrials 17.09%
3 Materials 13.97%
4 Healthcare 11.52%
5 Energy 6.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KATE
201
DELISTED
Kate Spade & Company
KATE
$33K 0.01%
868
-1,490
-63% -$53.4K
AROC icon
202
Archrock
AROC
$6.33B
$32K 0.01%
718
-399
-36% -$17.2K
EVR icon
203
Evercore
EVR
$13.1B
$32K 0.01%
+561
New +$30.8K
ODFL icon
204
Old Dominion Freight Line
ODFL
$48.5B
$32K 0.01%
1,524
-1,638
-52% -$33K
PFPT
205
DELISTED
Proofpoint, Inc.
PFPT
$32K 0.01%
867
-1,998
-70% -$63.9K
GEVA
206
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
$32K 0.01%
305
-170
-36% -$14.5K
RARE icon
207
Ultragenyx Pharmaceutical
RARE
$2.65B
$31K 0.01%
699
-27
-4% -$1.11K
SSTK icon
208
Shutterstock
SSTK
$205M
$31K 0.01%
373
-146
-28% -$10.6K
VNCE icon
209
Vince Holding Corp
VNCE
$76.2M
$31K 0.01%
+86
New +$24.9K
TPC
210
Tutor Perini Cor
TPC
$4.57B
$31K 0.01%
+963
New +$29.2K
VRTU
211
DELISTED
Virtusa Corporation
VRTU
$31K 0.01%
+862
New +$29.4K
AYI icon
212
Acuity Brands
AYI
$9.88B
$30K 0.01%
218
-84
-28% -$10.7K
ACHC icon
213
Acadia Healthcare
ACHC
$3.17B
$29K 0.01%
635
-244
-28% -$10.7K
ALNY icon
214
Alnylam Pharmaceuticals
ALNY
$36.3B
$29K 0.01%
462
-965
-68% -$57.4K
ANIP icon
215
ANI Pharmaceuticals
ANIP
$1.77B
$29K 0.01%
+849
New +$26.6K
AVNT icon
216
Avient
AVNT
$3.45B
$29K 0.01%
680
-729
-52% -$28.5K
DWRE
217
DELISTED
DEMANDWARE INC COM STK (DE)
DWRE
$29K 0.01%
416
-1,278
-75% -$73.3K
GWRE icon
218
Guidewire Software
GWRE
$11.5B
$28K 0.01%
689
-981
-59% -$38.9K
ECOL
219
DELISTED
US Ecology, Inc.
ECOL
$28K 0.01%
+571
New +$26.2K
ZOES
220
DELISTED
Zoe's Kitchen, Inc.
ZOES
$27K 0.01%
+787
New +$22.8K
PCTY icon
221
Paylocity
PCTY
$6.71B
$26K 0.01%
+1,204
New +$23.7K
XLRN
222
DELISTED
Acceleron Pharma
XLRN
$26K 0.01%
764
-454
-37% -$15.2K
HW
223
DELISTED
Headwaters Inc
HW
$26K 0.01%
+1,885
New +$24K
MIC
224
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
$25K 0.01%
+396
New +$23.4K
ALGN icon
225
Align Technology
ALGN
$12B
$24K 0.01%
435
-855
-66% -$44.5K
7 8
9
10 11

Similar funds

AHS
Aspiriant Holdings S3 Los Angeles, California $233M AUM 3.13% 1-Year Est. Return
KM
KS Management New York $198M AUM 43.09% 1-Year Est. Return
TC
Taylor Cottrill New London, New Hampshire $194M AUM 1.15% 1-Year Est. Return
IA
Ibbotson Associates Chicago, Illinois $193M AUM 3.52% 1-Year Est. Return
BL
Bolton LP Greenwich, Connecticut $259M AUM 30.92% 1-Year Est. Return
QA
Quintium Advisors Knoxville, Tennessee $160M AUM 2.85% 1-Year Est. Return
THP
Telegraph Hill Partners San Francisco, California $159M AUM
SGH
Schonfeld Group Holdings Jericho, New York $158M AUM 12.17% 1-Year Est. Return

Stonehage Fleming (UK)'s Q2 2014 Portfolio in Review

As of Q2 2014, Stonehage Fleming (UK) held 357 positions worth $248M, up 4.8% from $236M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Stonehage Fleming (UK) withdrew a net $9.42M in Q2 2014, closing 96 positions and reducing 132 holdings. Its most notable exit was ProShares Short S&P500, an estimated $6.22M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Industrials and Materials.

Against the trend, Stonehage Fleming (UK) opened a new position in ProShares Short Dow30 worth $6M.

  • Stonehage Fleming (UK)'s largest Q2 2014 buy was ProShares Short Dow30: 59,500 shares worth $6M.
  • Stonehage Fleming (UK) added most to Cemex in Q2 2014, an estimated $11.5M increase.
  • Stonehage Fleming (UK)'s biggest Q2 2014 reduction was Emerson Electric, cutting an estimated $3.22M.
  • Stonehage Fleming (UK) fully exited ProShares Short S&P500 in Q2 2014, selling an estimated $6.22M.
  • Stonehage Fleming (UK)'s ten largest holdings make up 29% of its $248M portfolio in Q2 2014.
  • Stonehage Fleming (UK) opened 54 new positions and closed 96 in Q2 2014.
  • Stonehage Fleming (UK)'s portfolio value rose 4.8% quarter-over-quarter to $248M.

Based on Stonehage Fleming (UK)'s 13F filing for Q2 2014, filed 11 Oct 2019.